At a glance
ClinicalIndex Comparison RecordN/ACompleted· 200 enrolled
Drug / intervention
Lacrosse NSE ALPHA coronary dilatation catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study to EXhibit Percutaneous Coronary Artery Dilatation With Non-Slip Element Balloon (EXPANSE-PTCA)
In Brief
A clinical study evaluating Lacrosse NSE ALPHA coronary dilatation catheter for Coronary Stenosis and 2 related conditions. Completed, enrolled 200 participants across 10 sites.
Detailed Summary
The objective of this study is to evaluate safety and effectiveness of the Lacrosse NSE ALPHA coronary dilatation catheter during PCI in subjects with stenotic coronary arteries.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsBright Research Partners
Timeline
N/ACompletedFinished
20222023202420252026
First PostedAug 2021
Enrollment StartDec 2021
Primary CompletionDec 2022
TodayJul 2026
First PostedAug 2, 2021
Enrollment StartDec 17, 2021
Primary CompletionDec 16, 2022
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 4.9 years ago
Interventions
Lacrosse NSE ALPHA coronary dilatation catheterdevice
The Lacrosse NSE ALPHA is a rapid exchange percutaneous transluminal coronary angioplasty balloon catheter with non-slip element nylon threads that focus dilatation force to reduce balloon slippage during inflation.